Published online before print September 9, 2004, doi: 10.1161/01.RES.0000144796.82787.6f
© 2004 American Heart Association, Inc.
Integrative Physiology |
Targeted Disruption of cd73/Ecto-5'-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response
From the Department of Cardiovascular Physiology (P.K., B.Ö., U.F., A.B., U.K.M.D., A.M., Z.D., A. Gödecke, J. Schrader), Heinrich-Heine-University, Düsseldorf, Germany; Biozentrum der J.W. Goethe-Universität, AK Neurochemie, Zoologisches Institut (N.B., H.Z.), Frankfurt am Main, Germany; Departments of Molecular Cardiovascular Research and Cardiology (A.Z., C.W.), University of Technology, Aachen, Germany; Cardiovascular Research Center and Department of Biomedical Engineering (Y.H., M.L.S., K.L.), Charlottesville, Va; Department of Biochemistry and Molecular Genetics (A. Gear), University of Virginia Health Sciences Center, Charlottesville, Va; Department of Pharmacology (A.A.W.), Heinrich-Heine-University, Düseldorf, Germany; and Centre de Recherche en Rhumatologie et Immunologie (J. Sévigny), Sainte-Foy (Québec), Canada. The present address for P.K. is the Department of Cell Biology, Intercollegiate Faculty of Biotechnology, Medical University of Gda
sk, Poland.
Correspondence to Juergen Schrader, MD, Heinrich-Heine-University Duesseldorf, Department of Cardiovascular Physiology, Moorenstrasse 5, 40225 Duesseldorf, Germany. E-mail schrader{at}uni-duesseldorf.de
To investigate the role of adenosine formed extracellularly in vascular homeostasis, mice with a targeted deletion of the cd73/ecto-5'-nucleotidase were generated. Southern blot, RT-PCR, and Western blot analysis confirmed the constitutive knockout. In vivo analysis of hemodynamic parameters revealed no significant differences in systolic blood pressure, ejection fraction, or cardiac output between strains. However, basal coronary flow measured in the isolated perfused heart was significantly lower (–14%; P<0.05) in the mutant. Immunohistochemistry revealed strong CD73 expression on the endothelium of conduit vessels in wild-type (WT) mice. Time to carotid artery occlusion after ferric chloride (FeCl3) was significantly reduced by 20% in cd73–/– mice (P<0.05). Bleeding time after tail tip resection tended to be shorter in cd73–/– mice (–35%). In vivo platelet cAMP levels were 0.96±0.46 in WT versus 0.68±0.27 pmol/106 cells in cd73–/– mice (P<0.05). Under in vitro conditions, platelet aggregation in response to ADP (0.05 to 10 µmol/L) was undistinguishable between the two strains. In the cremaster model of ischemia–reperfusion, the increase in leukocyte attachment to endothelium was significantly higher in cd73–/– compared with WT littermates (WT 98% versus cd73–/– 245%; P<0.005). The constitutive adhesion of monocytes in ex vivo–perfused carotid arteries of WT mice was negligible but significantly increased in arteries of cd73–/– mice (P<0.05). Thus, our data provide the first evidence that adenosine, extracellularly formed by CD73, can modulate coronary vascular tone, inhibit platelet activation, and play an important role in leukocyte adhesion to the vascular endothelium in vivo.
Key Words: transgenic mice • adenosine • ecto-5'-nucleotidase • vascular inflammation • thrombosis
Related Article:
Circ. Res. 2004 95: 752-753.
This article has been cited by other articles:
 |
|
 |
|
  C.E. Chadjichristos, K.E.L. Scheckenbach, T.A.B. van Veen, M.Z. Richani Sarieddine, C. de Wit, Z. Yang, I. Roth, M. Bacchetta, H. Viswambharan, B. Foglia, et al. Endothelial-Specific Deletion of Connexin40 Promotes Atherosclerosis by Increasing CD73-Dependent Leukocyte Adhesion Circulation, January 5, 2010; 121(1): 123 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hasegawa, D. Bouis, H. Liao, S. H. Visovatti, and D. J. Pinsky Ecto-5' Nucleotidase (CD73)-Mediated Adenosine Generation and Signaling in Murine Cardiac Allograft Vasculopathy Circ. Res., December 5, 2008; 103(12): 1410 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. S. Li, R. Y. K. Man, P. M. Vanhoutte, and G. P. H. Leung Stimulation of ecto-5'-nucleotidase in human umbilical vein endothelial cells by lipopolysaccharide Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1177 - H1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Hart, D. Kohler, T. Eckle, D. Kloor, G. L. Stahl, and H. K. Eltzschig Direct Treatment of Mouse or Human Blood With Soluble 5'-Nucleotidase Inhibits Platelet Aggregation Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1477 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis PNAS, July 8, 2008; 105(27): 9325 - 9330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mikhailov, A. Sokolovskaya, G. G. Yegutkin, H. Amdahl, A. West, H. Yagita, R. Lahesmaa, L. F. Thompson, S. Jalkanen, D. Blokhin, et al. CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis J. Immunol., July 1, 2008; 181(1): 464 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Peng, P. Fernandez, T. Wilder, H. Yee, L. Chiriboga, E. S. L. Chan, and B. N. Cronstein Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis FASEB J, July 1, 2008; 22(7): 2263 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, J. Fassett, X. Hu, G. Zhu, Z. Lu, Y. Li, J. Schnermann, R. J. Bache, and Y. Chen Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction Hypertension, June 1, 2008; 51(6): 1557 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jalkanen and M. Salmi VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 18 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Barnes, H. Dobrzynski, S. Foppolo, P. R. Beal, F. Ismat, E. R. Scullion, L. Sun, J. Tellez, M. W.L. Ritzel, W. C. Claycomb, et al. Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH Circ. Res., September 1, 2006; 99(5): 510 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y. Huang, V. Vallon, H. Zimmermann, P. Koszalka, J. Schrader, and H. Osswald Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo Am J Physiol Renal Physiol, August 1, 2006; 291(2): F282 - F288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zernecke, K. Bidzhekov, B. Ozuyaman, L. Fraemohs, E. A. Liehn, J. M. Luscher-Firzlaff, B. Luscher, J. Schrader, and C. Weber CD73/Ecto-5'-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation Circulation, May 2, 2006; 113(17): 2120 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Volmer, L. F. Thompson, and M. R. Blackburn Ecto-5'-Nucleotidase (CD73)-Mediated Adenosine Production Is Tissue Protective in a Model of Bleomycin-Induced Lung Injury J. Immunol., April 1, 2006; 176(7): 4449 - 4458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Vekaria, D. G. Shirley, J. Sevigny, and R. J. Unwin Immunolocalization of ectonucleotidases along the rat nephron Am J Physiol Renal Physiol, February 1, 2006; 290(2): F550 - F560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Adair Growth regulation of the vascular system: an emerging role for adenosine Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Linden Adenosine in Tissue Protection and Tissue Regeneration Mol. Pharmacol., May 1, 2005; 67(5): 1385 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Olsson Cardiovascular Ecto-5'-Nucleotidase: An End to 40 Years in the Wilderness? Circ. Res., October 15, 2004; 95(8): 752 - 753. [Full Text] [PDF]
|
|